Cardinal Infrastructure Group reported a surprising net loss of $11 million in Q3 2026, a sharp reversal from prior profits, causing its shares to fall over 60%. The company revealed significant project cost overruns and withdrew its full-year financial guidance, raising concerns about management and operational failures. An ongoing investigation is examining whether Cardinal misled investors during its June 2026 secondary offering, which raised over $318 million. Investors who suffered losses are encouraged to submit claims as the company faces legal scrutiny and executive changes.
Cardinal Infrastructure Group's recent financial troubles provide context for readers. For those following the Industrials sector, here is Pluang's market snapshot as of Nov 13, 2026 22:52 WIB: out of 135 priced US Industrials stocks, 55 rose and 80 fell. Among notable movers, Plug Power Inc (PLUG) dropped 8.10% to USD 1.14 with a typical hold time of 43 days and a Pluang order activity skewed 78% Buy. FuelCell Energy Inc (FCEL) fell 7.41% to USD 9.49, held typically for 49 days, with 87% Buy orders. INNIO N.V. (INIO) declined 6.93% to USD 14.11, held for just 5 days, with balanced buy-sell orders at 50%.
Susan R. Burns, Ph.D., President of the University of Mount Saint Vincent, has been awarded the 2027 Courageous Leadership Award for her visionary and bold leadership. Since 2021, she has led the university through significant transformation, includi...
Solo, a company specializing in privacy-preserving human verification, has integrated its SDK into JellyJelly, a social video app co-founded by Venmo's co-founder. This integration ensures that every JellyJelly account belongs to a real, unique perso...
The U.S. market for AI-enabled ophthalmic diagnostic devices is projected to grow from $72.5 million in 2026 to $267.2 million by 2033, expanding at a 20.5% CAGR. Growth is driven by rising diabetes-related eye diseases, FDA clearances for autonomous...
The global medical display monitors market, valued at $2.8 billion in 2025, is projected to grow to $4.0 billion by 2033 with a CAGR of 4.6%. Growth is fueled by rising adoption of digital imaging systems, demand for accurate diagnostics, and healthc...
Oppenheimer downgraded Enovix from Outperform to Perform as the company expands production in South Korea and shifts focus to drone and smart-eyewear customers. Enovix reported a 38% revenue increase to $11 million in Q3 but saw its adjusted loss wid...
